Sonalleve MR-HIFU is an innovative therapeutic platform that combines real time MR imaging and thermometry with thermal ultrasound to enable precise and incision-free ablation of diseased tissue. Sonalleve is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

Profound Announces Definitive Agreement with Philips to Acquire Sonalleve MR-HIFU

Creating A Market Leader in MR-Ultrasound Ablation Therapy

Enabling Safe, Personalized, Precise and Fast Ablative Treatment Options for Diseased Tissue